We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Expert Opinion / Cases · October 11, 2019

Immunotherapy Schedule Recommendation for Newly Diagnosed Metastatic Melanoma

Written by
Matthew Stein MD


Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Nethanel Asher

    I would start with a single agent anti PD 1. Seeing his advanced age, he is expected to respond much better than younger patients (more than half achieve CRs. ref: Ben-Betzalel et al EJC 2018). Otherwise, I'd start an inverse doses combination (CM 511) - that has similar response rates but is much less toxic.

  • Jun 25, 2021

    Pending Moderator approval.

Further Reading